tiprankstipranks
Analyst Profile
Followed by 25 other investors
.
Ryan Daniels

Ryan Daniels

William Blair
Wall Street Analyst
Ranked #2,260 out of 8,050 Analysts on TipRanks (#4,379 out of 21,576 overall experts)

Success Rate

47%
43 out of 92 Profitable Transactions

Average Return

7.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Ryan Daniels's ratings since 2010 and opened each position for the duration of 1 Year:
46.74% of your transactions would have been profitable with an average return of 7.0%

Stock Rating Distribution

149Ratings
66.44% Buy
33.56% Hold
0.00% Sell
Distribution of Ryan Daniels's ratings

Additional Information

Main Sector:Technology
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Arrowhead Pharmaceuticals, Inc.
(ARWR)
Rating Type:Buy
Dates:Sep 27, 2017 - Sep 27, 2018
Gain:381.00%
The most profitable rating made by Ryan Daniels

Ryan Daniels's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
LCAV
LCA Vision
Oct 26, 2010
Hold
Reiterated
0.00%
1
GWAY
Greenway Medical Technologies
Sep 24, 2013
Hold
Downgraded
0.00%
1
~ATHN
Athenahealth
Dec 10, 2014
Hold
Reiterated
0.00%
2
IPCM
IPC Healthcare
Aug 04, 2015
Hold
Downgraded
100%
+14.90%
2
Mednax
Sep 22, 2015
Buy
Reiterated
0%
-22.80%
2
Stericycle
Oct 09, 2015
Buy
Reiterated
50%
-18.70%
2
IMPR
Imprivata
Oct 15, 2015
Hold
Downgraded
0.00%
1
HealthStream
Oct 19, 2015
Buy
Reiterated
100%
+32.30%
2
Premier
Nov 09, 2015
Buy
Reiterated
0%
-13.20%
3
Computer Programs and Systems
Nov 25, 2015
Hold
Reiterated
0.00%
2
List of latest recommendations made by Ryan Daniels. Click to expand and see Ryan Daniels's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More